ライフサイエンスコーパス: health care cost

1 h in-hospital mortality, length of stay, and health care cost.

2 n morbidity, mortality, quality of life, and health-care cost.

3 ted States and are associated with increased health care costs.

4 Cancer-related expenditures are increasing health care costs.

5 d mental distress and a substantial cause of health care costs.

6 ury stage, patient participation in care and health care costs.

7 not associated with significant reduction in health care costs.

8 cosmetic problems, and its repair increases health care costs.

9 ed inpatient stays being a primary driver of health care costs.

10 ure to the health care setting, and decrease health care costs.

11 that affects both clinical care and overall health care costs.

12 elative to their prevalence, impairment, and health care costs.

13 ssion, improve patient outcomes, and control health care costs.

14 e represents an effective approach to reduce health care costs.

15 icant morbidity and mortality and additional health care costs.

16 tes, improve cosmetic outcomes, and decrease health care costs.

17 HEN improves clinical outcomes and decreases health care costs.

18 stigmatization, patient distress, and higher health care costs.

19 is a major cause of morbidity and increased health care costs.

20 th increasing life expectancy and decreasing health care costs.

21 tes, improve cosmetic outcomes, and decrease health care costs.

22 eliminate unnecessary procedures, and reduce health care costs.

23 ve postoperative outcomes and reduce overall health care costs.

24 bstantially reduce morbidity, mortality, and health care costs.

25 e used to assess time to treatment and total health care costs.

26 are associated with increased morbidity and health care costs.

27 trends on the associated disease burden and health care costs.

28 f surgery is more likely to reduce long-term health care costs.

29 pirical evidence to anticipate the effect on health care costs.

30 rior resection increased mortality rates and health care costs.

31 e major sources of morbidity, mortality, and health care costs.

32 medical and mental disorders, and increased health care costs.

33 e airway pressure, patient satisfaction, and health care costs.

34 e, unnecessary antibiotic use, and increased health care costs.

35 ng among this cohort is critical to reducing health care costs.

36 d is associated with increased morbidity and health care costs.

37 ancer Quality of Life Questionnaire C30) and health care costs.

38 28) per patient and did not lower subsequent health care costs.

39 le net benefit" (51%) as a means of reducing health care costs.

40 al therapy, the hospital length of stay, and health care costs.

41 d morbidity, use of health care support, and health care costs.

42 produce considerable morbidity and increase health care costs.

43 services and inflation-adjusted estimated VA health care costs.

44 is associated with significant morbidity and health care costs.

45 fectious morbidity, mortality, and increased health care costs.

46 sts is an important component of unnecessary health care costs.

47 e with significant morbidity, mortality, and health care costs.

48 bidity, length of hospital stay, and overall health care costs.

49 s but represents a substantial percentage of health care costs.

50 ysis could reduce considerable morbidity and health care costs.

51 ietal concern and generate significant human health care costs.

52 increased risk of adverse outcomes and high health care costs.

53 eterminants of caregiving needs and societal health care costs.

54 nical outcomes, and is associated with large health care costs.

55 tuberculosis results in additional human and health care costs.

56 effects on quality of life, disability, and health care costs.

57 with adverse quality of life, morbidity, and health care costs.

58 ive better outcomes in the setting of rising health care costs.

59 es morbidity, duration of hospital stay, and health care costs.

60 l as broad societal effects with substantial health care costs.

61 dialysis and is a significant contributor to health care costs.

62 nd population health outcomes while reducing health care costs.

63 lly save approximately 80 million dollars in health care costs.

64 otential effect of such urine RNA testing on health care costs.

65 ates, improve cosmetic outcome, and decrease health care costs.

66 nificant morbidity, mortality, and increased health care costs.

67 edical conditions and resultant reduction in health care costs.

68 of people each year and add significantly to health care costs.

69 ducing PAD-related morbidity, mortality, and health care costs.

70 reby improving patient outcomes and reducing health care costs.

71 ntified as an opportunity for containment of health care costs.

72 nd late sequelae, accounting for substantial health care costs.

73 health care and a primary driver of growing health care costs.

74 oring tests was associated with higher total health care costs.

75 ratory diagnostic testing leads to increased health care costs.

76 beral threshold with respect to morbidity or health care costs.

77 d morbidity and mortality rates, and soaring health-care costs.

78 ted with morbidity, mortality, and increased health-care costs.

79 clinicians to take leadership in reining in health-care costs.

80 f asthma control, patient acceptability, and health-care costs.

81 is associated with poor health and increased health-care costs.

82 nditions are the leading causes of death and health-care costs.

83 audiovisual programme, so might also reduce health-care costs.

84 and improve outcomes while reducing overall health care costs ( 7 , 8 ).

85 ghest decrease in net overall median monthly health care costs (-$85 [interquartile range, -$116 to -

86 exacerbations had significantly higher total health care costs ($9223 vs $5011, P < .0001) and asthma

87 lion/year from avoided mortality and reduced health care costs (95% CI: $2.7 billion, $5.0 billion].

88 Health-care costs accounted for euro8 billion (75% of to

89 The outcomes measured were health-care costs accrued in the last year of life, numb

90 were associated with significantly increased health care costs after 4 common surgical procedures.

91 reshold, reduces postoperative morbidity and health care costs after cardiac surgery is uncertain.

92 y be responsible for increased morbidity and health care costs after cardiac surgery.

93 olume both contribute to high and increasing health care costs, along with high administrative costs,

94 for Medicare and Medicaid Services to reduce health care cost and improve quality.

95 ence of the direction of association between health care cost and quality is inconsistent.

96 (95% CI, $2247-$3558; P < .001) annual total health care costs and $2599 (95% CI, $1985-$3212; P < .0

97 s, with a concomitant concerning increase in health care costs and burden to children with this disea

98 ciated with a high mortality and substantial health care costs and cause therapeutic problems due to

99 In the current context of rising health care costs and decreasing sustainability, it is b

100 In extreme users, total health care costs and end-of-life health care utilizatio

101 ct cost comparisons between intervention and health care costs and energy savings.

102 Excessive use of medical imaging increases health care costs and exposure to ionizing radiation (a

103 Current efforts to reduce health care costs and improve health care quality requir

104 The increased health care costs and morbidity linked to appendiceal ru

105 Health care costs and obesity are both rising.

106 listic decision analytical model to estimate health care costs and outcomes (quality-adjusted life-ye

107 ransitions of care, resulting in substantial health care costs and persistent, profound disability.

108 uly 2012 and March 2013 about causes of high health care costs and proposed cost-control measures.

109 Health care costs and QALYs associated with the current

110 adults with uncontrolled asthma in terms of health care costs and quality-adjusted life years (QALYs

111 Ocular injuries and outcomes and health care costs and reimbursements, which were generat

112 by SCS exposure and quantify the associated health care costs and resource use in patients with seve

113 The actual health care costs and theoretical cost differences for t

114 ectomy results in a significant reduction in health care costs and utilization in the short- and long

115 loping and testing approaches to controlling health care costs and value.

116 e worldwide; in isolation, it doubles annual health care costs and, when associated with comorbid men

117 age, an infected individual incurs US$474 in health-care costs and 0.51 DALYs annually.

118 ly infected individuals is $24.73 billion in health-care costs and 29,385,250 DALYs.

119 rger proportion of economic burden (80.8% of health-care costs and 60.4% of indirect costs), whereas

120 lly, the annual burden is $627.46 million in health-care costs and 806,170 DALYs.

121 Direct health-care costs and DALYs were estimated for coronary

122 We calculated annual and lifetime health-care costs and disability-adjusted life-years (DA

123 nown about how specific interventions affect health-care costs and health-related quality-of-life out

124 Health-care costs and, importantly, caregiver burden, ar

125 may have a positive impact on patient care, health care costs, and antibiotic stewardship.

126 otic usage, improve clinical outcomes, lower health care costs, and avoid emergence of drug resistanc

127 se national health survey, vital statistics, health care costs, and cohort study outcomes data as mod

128 mulation model to project clinical outcomes, health care costs, and cost-effectiveness of CCTA, compa

129 this study was to project clinical outcomes, health care costs, and cost-effectiveness of coronary co

130 eases and inflict significant economic loss, health care costs, and emotional burdens.

131 h care services, offset the burden of rising health care costs, and enhance the quality of life among

132 stantial costs, including public assistance, health care costs, and income losses due to lower educat

133 morbidity, extended hospital stay, increased health care costs, and reduced quality of life.

134 cluding changes in care delivery, escalating health care costs, and the need to keep up with rapid sc

135 mately $53.4 billion annually in lost wages, health-care costs, and criminal costs.

136 were effective for reduction of consumption, health-care costs, and health-related quality of life lo

137 for reasons of increasing need, to stabilise health-care costs, and to accommodate patient preference

138 nd 365 days after the index procedure; total health care costs; and estimated days off from work owin

139 life-years and $10 billion to $24 billion in health care costs annually.

140 Physicians' views about health care costs are germane to pending policy reforms.

141 re resources and for reduction of individual health care costs are needed in Korea.

142 l effects of smoking status on perioperative health care costs are unclear.

143 re disease because morbidity, mortality, and health-care costs are substantial and the unmet need is

144 gorithms, which balance patient benefits and health care costs, are needed.

145 with CML will have a great effect on future health care costs as long as continuous TKI treatment is

146 y for improved patient care and reduction in health-care costs, as will be further evaluated in futur

147 o determine the lifetime health benefits and health care costs associated with intensive control vers

148 The direct health care costs associated with treatment of adhesion-

149 middle age is strongly associated with lower health care costs at an average of 22 years later in lif

150 d the differential effect of serious SSIs on health care costs at the upper end of the cost distribut

151 Monthly direct health care costs authorized by Aid for AIDS were averag

152 with cancer bear a greater portion of their health care costs, because cancer treatment costs have i

153 The mean difference in direct health care costs between groups was pound107.53 ( pound

154 mplicated appendicitis, disability days, and health care costs between nonoperative management and su

155 This study compared direct health care costs between patients with moderate/severe

156 The health care cost burden associated with OA is quite larg

157 antial burden in terms of high incidence and health care costs but is excluded by most cancer registr

158 Surgical site infections (SSIs) may increase health care costs, but few studies have conducted an ana

159 s are common and contribute to morbidity and health care costs, but their effects on mortality are un

160 nd private initiatives have sought to reduce health care costs by making health care prices more tran

161 he government and private insurers to reduce health care costs by restricting access to expensive new

162 otential for improving outcomes and reducing health-care costs by eliminating unnecessary invasive pr

163 g patients but also save direct and indirect health-care costs by streamlining procedures, minimizing

164 d in an observation unit (OU) reduces 1-year health care costs compared with inpatient care.

165 Using the Pennsylvania Health Care Cost Containment Council database, we identi

166 procedure volume data from the Pennsylvania Health Care Cost Containment Council, we calculated prox

167 In this survey about health care cost containment, US physicians reported hav

168 This article examines the options for health care cost control under the Obama administration.

169 The overall health care cost could have decreased by $293.61 per pat

170 Associations of eGFR with total health care costs defined by Medicare payments were asse

171 sociated with significant mortality and high health care costs, despite appropriate initial antibioti

172 Total health care costs did not differ between CCMs and compar

173 data indicated that injection frequency and health care costs did not differ for anti-VEGF treatment

174 Total mean health care costs did not differ significantly between t

175 Total and asthma-related health care costs during the 1-year study period after t

176 Compared with never smokers, health care costs during the first year after hospital d

177 Quarterly and yearly total health care costs, ED visits, hospital days, and prescri

178 High health care costs encourage initiatives that avoid overu

179 ntly associated with a 1.26-fold increase in health care costs (estimated, $1715; 95% CI, $338-$2853)

180 Health-care cost euro7.3 billion (62% of total costs), p

181 mental health are associated with increased health care costs even many years later, especially for

182 After 2 years of anticoagulation therapy, health care costs (excluding the study drug) of patients

183 Health care costs, excluding the index surgery, were est

184 Health care costs, family responsibilities, psychologica

185 impact of surgical site infections (SSIs) on health care costs following common ambulatory surgical p

186 To evaluate geographic variation in health care cost for management of AKs and the associati

187 breastfeeding as follows: the sum of direct health care costs for diseases whose risk increases when

188 The estimated VA health care costs for MA enrollees totaled $13.0 billion

189 use of laparoscopy is associated with lower health care costs for many operations, including colecto

190 nt, were equal to or greater than the actual health care costs for similar proportions of patients an

191 tion, both resulted in a decrease in overall health care costs for the patient cohort.

192 primary care patients, the mean total annual health care costs for the three years after diagnosis co

193 da (which indicate prolonged and even higher health-care costs for patients diagnosed late) suggest t

194 Monthly standardized health care costs from commercial claims data from Janua

195 model to apply SPRINT treatment effects and health care costs from national sources to a hypothetica

196 We estimated health-care costs from expenditure on care in the primar

197 ines in tobacco-related deaths, and diminish health-care costs from tobacco-related diseases.

198 Concerns about patient safety, quality, and health care costs have increased demand for outcome meas

199 States and Europe, efforts to reduce soaring health care costs have led to intense scrutiny of both s

200 actor in US economic growth, because growing health care costs have made US corporations less competi

201 Given the widespread concerns about rising health care costs in general and the costs of advanced i

202 an both improve control and save medium-term health care costs in high TB burden settings.

203 cardiovascular risk factors, average annual health care costs in later life were incrementally lower

204 study sought to evaluate the association of health care costs in later life with cardiorespiratory f

205 dens in middle age are associated with lower health care costs in later life.

206 The mean +/- SD total health care costs in the 2 years preceding surgery were

207 pain-related pharmacotherapy and high total health care costs in the 2-year period preceding surgery

208 Bariatric surgery does not reduce overall health care costs in the long term.

209 Health care costs in the United States are increasing fa

210 Health care costs in the United States are increasing un

211 Unsustainable rising health care costs in the United States have made reducin

212 ported having some responsibility to address health care costs in their practice and expressed genera

213 ations account for substantial morbidity and health-care costs in paediatric and adult onset Crohn's

214 , has been the focus of debates about rising health care costs, inappropriate use, and patient safety

215 ice of locking solution would affect overall health care costs, including the cost of locking solutio

216 ucoma medications is low in Taiwan, although health care costs, including the cost of medication, are

217 Health care costs increase in patients with more severe

218 Total expected lifetime health care costs increased by $2952, reflecting the hig

219 g the effect of cardiorespiratory fitness on health care costs independent of these risk factors.

220 ecember 31, 2012, made available through the Health Care Cost Institute.

221 The need is urgent to bring US health care costs into a sustainable range for both publ

222 or simply leads to greater complications and health care costs is commonly debated in the literature.

223 accountable care, understanding variation in health care costs is critical to reducing health care sp

224 of RS testing on breast cancer treatment and health care costs is much greater in younger women.

225 s medical conditions and resultant secondary health care costs is not well understood.

226 One driver of increasing health care costs is the use of radiologic imaging proce

227 ients, the likely impact of these efforts on health care costs is uncertain.

228 ssion and survival, but its effect on direct health care costs is unclear.

229 tic treatment on patient quality of life and health care costs is unknown.

230 Detailed insight into disease-specific health-care costs is critical because it co-determines t

231 lation and future generations, and to reduce health-care costs is inadequately recognised.

232 ly address both the level and growth of U.S. health care costs, it is critical to first understand co

233 s, Mydriasert resulted in overall savings in health-care costs, mainly associated with reduced nursin

234 Other outcomes included health care cost measures (adjusted to 2013 dollars).

235 ly; P < .001) and lower appendicitis-related health care costs (median [IQR], $4219 [$2514-$7795] vs

236 gical emergency with considerable associated health-care costs, morbidity, and mortality.

237 ificant contribution of surgical spending to health care costs, most surgeons are unaware of their op

238 ed $100 billion in annual incremental direct health care costs nationwide.

239 The primary outcome was average annual health care costs obtained from Medicare standard analyt

240 national average of $46,400 in attributable health care cost of postoperative pneumonia and a benchm

241 This study aimed to determine the direct health care costs of CRS from the perspective of the US

242 icaid claims analysis compared mean 18-month health care costs of patients with newly diagnosed AR wh

243 disorders of the blood represented an annual health-care cost of euro159 per ten citizens.

244 Across the EU, the health-care costs of cancer were equivalent to euro102 p

245 provide reliable up-to-date estimates of the health-care costs of excess weight and emphasise the nee

246 ven cost-saving, in settings where long-term health-care costs of late-diagnosed patients in high-pre

247 health care itself; i.e., how people access health care, costs or other barriers to the provision of

248 y experience financial burden as a result of health care costs, particularly because these patients o

249 as associated with lower mean monthly direct health care costs, particularly reduced hospitalization

250 The overall health care cost per episode was 3 times lower in group

251 mes and Measures: Mean total and AAA-related health care cost per life-year and per quality-adjusted

252 Incremental health care cost per life-year gained.

253 The mean health care cost per patient was $3437.24 ($1334.68).

254 th care services, adjusted mean annual total health care costs per person, and adjusted mean annual n

255 and US$1220 (95% CI: -US$2416, -US$24) lower health-care costs per team diabetes patient in the past

256 both cohorts, as did annual per-beneficiary health care costs (pre-MOC period, $5157 for MOC-require

257 Direct health-care costs, productivity losses, and disability-a

258 Increased health care costs, prolonged hospital stays, and long-te

259 ree to which such surgery is associated with health care cost reductions that are sustained over time

260 ntal quality-adjusted life years (QALYs) and health-care costs related to back pain.

261 Health care costs remain high at $3.2 trillion spent ann

262 Total health care costs remained higher in the three years aft

263 The effect of such a strategy on health care costs remains controversial.

264 n Hospital Association Annual Survey and the Health Care Cost Report Information System from the US C

265 Research demonstrates significant health care cost savings conferred by allergen-specific

266 Annual health care cost savings in the United States ranging fr

267 The magnitude of 18-month health care cost savings realized by AIT-treated adults

268 es included reduction in delay to treatment, health care cost savings, and decrease in no-show rate.

269 ve prostate cancer with consequent potential health care cost savings.

270 thresholds and was estimated to increase US health care costs substantially.

271 higher medical complication rates and higher health care costs, suggesting that more effective care m

272 initiating AIT incurred significantly lower health care costs than matched control subjects beginnin

273 $10,644, P<.0001) lower mean 18-month total health care costs than matched control subjects, with si

274 rbations had higher total and asthma-related health care costs than those without exacerbations.

275 ity, improving quality of life, and reducing health care costs through early detection of colon cance

276 ors to examine the impact of SSIs on 180-day health care costs throughout the cost distribution.

277 to patients as well as controlling excessive health care costs to both patients and health care facil

278 lected medical conditions and predicted high health care costs to instruct them about shared decision

279 nd RYGB were associated with flattened total health care cost trajectories but RYGB patients experien

280 Median (interquartile range) total health care costs were $48663 ($32620-$71547) for patien

281 Length of stay and total health care costs were compared using multivariable line

282 When all health care costs were compared, the intervention group'

283 subjects, significantly lower 18-month mean health care costs were demonstrated overall (38%; $6,637

284 Health care costs were determined by multiplying the tot

285 Indirect health care costs were not included.

286 Oral health care costs were not increased by any single RF, r

287 Adjusted respiratory-related health care costs were significantly lower for HFA-beclo

288 88 person-years of follow-up, average annual health care costs were significantly lower forparticipan

289 djusted differences in total HZ-attributable health-care costs were $4762 and $6705 for commercial/Me

290 Health-care costs were estimated from expenditure on pri

291 Health-care costs were estimated from expenditure on pri

292 ect 0.01 (95% CI -0.03 to 0.04; p=0.787) and health-care costs were marginally reduced with CPAP (- p

293 art failure or cardiac deaths) and increased health-care costs when the value of providing that care

294 ) have a "major responsibility" for reducing health care costs, whereas only 36% reported that practi

295 age-related decrements in neuronal function, health care costs will continue to rise exponentially.

296 The health care costs will double from 2010 ($5.8 billion) i

297 bsequent to interventions, and then compared health care costs with energy savings and intervention c

298 o tap into remittances to finance additional health care costs without having to forego necessary exp

299 leading causes of mortality, disability, and health care costs worldwide.

300 ificant associated morbidity, mortality, and health care costs, yet limited data exist detailing tren